Indications and uses
"Helps prevent sunburn" "If used as directed with other protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun."
Stila Sheer color tinted moisturizer BS SPF20
- Manufacturer
- Stila Styles, LLC | MANA PRODUCTS
- Effective date
- 2013-11-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:37:51
Label at a glance#
ProductStila Sheer color tinted moisturizer BS SPF20 (All Shades)
Active ingredientTitanium Dioxide, Zinc Oxide
Label structure10 sections
Dosage and administration
Apply liberally 15 minutes before sun exposure Reapply: After 80 minutes of swimming or sweating Immediately after towel drying At least every 2 hours Children under 6 months: Ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection...
Storage and handling
Protect this product from excessive heat and direct sun
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active Ingredients | Purpose |
|---|---|
| Titanium Dioxide 5.00% | sunscreen |
| Zinc Oxide 5.00% | sunscreen |
Uses
"Helps prevent sunburn"
"If used as directed with other protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun."
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally 15 minutes before sun exposure
- Reapply:
- After 80 minutes of swimming or sweating
- Immediately after towel drying
- At least every 2 hours
- Children under 6 months: Ask a doctor
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 am – 2 pm
- Wear long-sleeved shirts, pants, hats and sunglasses
Inactive Ingredients
aluminum hydroxide, anthemis nobilis (chamomile) flower extract, boron nitride, butylene glycol, camellia oleifera (camilia oleifera) leaf extract, caprylyl glycol, cyclohexasiloxane, cyclopentasiloxane, dextrin palmitate, dimethicone, ginkgo biloba leaf extract, glycerin, hexylene glycol, lysine, magnesium ascorbyl phosphate, magnesium chloride, octyldodecyl neopentanoate, palmitic acid, panax ginseng (ginseng) root extract, peg/ppg-18/18 dimethicone, phenoxyethanol, phytantriol, potassium chloride, propylene glycol, retinyl palmitate, sodium chloride, sodium dehydroacetate,sodium hyaluronate, stearic acid, tetrahexyldecyl ascorbate, tocopherol, tocopheryl acetate, triethoxycaprylylsilane, water (aqua), zinc chloride, may contain (+\-): mica, titanium dioxide (ci 77891), iron oxides (ci 77491, 77492, 77499) <iln c121004>.
Other Information
Protect this product from excessive heat and direct sun
Questions?
stilacosmetics.com
SPL UNCLASSIFIED SECTION
dist. by stila styles, llc
los angeles, ca 90027
PRINCIPAL DISPLAY PANEL - 50 ml Tube Carton
stila
sheer color
tinted moisturizer
broad spectrum SPF 20
oil-free
water-resistant (80 minutes)
1.7 fl. oz./50 ml
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76049-556-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-30a6-f424-e053-dadaa90a57ce | Stila Sheer color tinted moisturizer broad spectrum SPF 20 (All Shades) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76049-556-01 | Stila Sheer color tinted moisturizer BS SPF20 (All Shades) | 50 mL in 1 TUBE | LOTION | 50 | 1 | |
| 76049-556-01 | Stila Sheer color tinted moisturizer BS SPF20 (All Shades) | 1 in 1 CARTON | LOTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| aluminum hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| asian ginseng | INACTIVE INGREDIENT | CUQ3A77YXI | 1 | |
| boron nitride | INACTIVE INGREDIENT | 2U4T60A6YD | 1 | |
| butylene glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| camellia oleifera leaf | INACTIVE INGREDIENT | 5077EL0C60 | 1 | |
| caprylyl glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| chamaemelum nobile flower | INACTIVE INGREDIENT | O2T154T6OG | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| cyclomethicone 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| ginkgo | INACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| hexylene glycol | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| hyaluronate sodium | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| lysine | INACTIVE INGREDIENT | K3Z4F929H6 | 1 | |
| magnesium ascorbyl phosphate | INACTIVE INGREDIENT | 0R822556M5 | 1 | |
| magnesium chloride | INACTIVE INGREDIENT | 02F3473H9O | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| octyldodecyl neopentanoate | INACTIVE INGREDIENT | X8725R883T | 1 | |
| palmitic acid | INACTIVE INGREDIENT | 2V16EO95H1 | 1 | |
| peg/ppg-18/18 dimethicone | INACTIVE INGREDIENT | 9H0AO7T794 | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| phytantriol | INACTIVE INGREDIENT | 8LVI07A72W | 1 | |
| potassium chloride | INACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| sodium dehydroacetate | INACTIVE INGREDIENT | 8W46YN971G | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| tetrahexyldecyl ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| vitamin a palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| zinc chloride | INACTIVE INGREDIENT | 86Q357L16B | 1 |
Products#
Every source-derived product name is available through these pages.
- Stila Sheer color tinted moisturizer BS SPF20 (All Shades)
- Titanium Dioxide and Zinc Oxide
- Titanium Dioxide
- Zinc Oxide
- aluminum hydroxide
- chamaemelum nobile flower
- boron nitride
- butylene glycol
- camellia oleifera leaf
- caprylyl glycol
- cyclomethicone 6
- cyclomethicone 5
- dimethicone
- ginkgo
- glycerin
- hexylene glycol
- lysine
- magnesium ascorbyl phosphate
- magnesium chloride
- octyldodecyl neopentanoate
- palmitic acid
- asian ginseng
- peg/ppg-18/18 dimethicone
- phenoxyethanol
- phytantriol
- potassium chloride
- propylene glycol
- vitamin a palmitate
- sodium chloride
- sodium dehydroacetate
- hyaluronate sodium
- stearic acid
- tetrahexyldecyl ascorbate
- tocopherol
- .alpha.-tocopherol acetate
- triethoxycaprylylsilane
- water
- zinc chloride
- mica
- ferric oxide red
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76049-556 | 76049-556-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | JELLY / NASAL | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRA-ARTERIAL | 278 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION / OPHTHALMIC | 0.22 %w/v | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION, EXTENDED RELEASE / ORAL | 1000 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | GRANULE, FOR SUSPENSION / ORAL | 162 mg | ||
| zinc chloride | ZINC CHLORIDE | 86Q357L16B | TABLET / ORAL | 14 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / ENDOTRACHEAL | 68 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| aluminum hydroxide | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | TABLET / ORAL | 50 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRALESIONAL | 0.9 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INFILTRATION | 0.3 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | INJECTION, SOLUTION / INTRATHECAL | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 69 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | PASTE / DENTAL | 0.5 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACARDIAC | 70 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INTRAVENOUS | 1 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| ferrosoferric oxide | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, COATED / ORAL | NA | ||
| hyaluronate sodium | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRACAUDAL | 210 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE / ORAL | 62 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAOCULAR | 320 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | FILM / BUCCAL | 0.27 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 69 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2c27ca70-fb9b-4c9f-9c78-93f9a6dc7c03 | b03ae115-7d63-46af-8af5-3f0573274887 | 2013-11-22 | Warnings | 2c27ca70-fb9b-4c9f-9c78-93f9a6dc7c03 b03ae115-7d63-46af-8af5-3f0573274887 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.